Role of PET/CT in initial evaluation of lymphoma patients

Abstract Background Accurate radiologic assessment of treatment response in lymphoma patients is important to evaluate the effectiveness and consequently predict relapse; value PET/CT for post-treatment prognosis prediction has been recently investigated. The aim this study highlight prognostic PET-CT metabolic volumetric parameters evaluation patients. Results Among included 40 patients, SUV, MTV, TLG were significantly lower a responsive group than non-responsive group. % changes all quantitative higher Conclusions This suggests that pre-treatment measures (except baseline SUVmax) are not conclusive patient treatment; however, ?SUVmax, ?MTV, ?TLG% from end therapy could be used predicting treatment, determining prognosis, suggesting relapse.